Skip to main content

Table 1 Subject demographics and baseline characteristics.

From: Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery

Characteristic

Female subjects

Male subjects

Race, n

  

Caucasian

30

4

African American

11

0

Asian

0

1

Hispanic

8

1

Age, years

  

Mean (SD)

7.3 (1.9)

7.9 (2.0)

Range

1.2–9.4a

4.1–9.5

Weight, kg

  

Mean (SD)

33.6 (9.72)

32.4 (8.96)

Range

13.0–52.2

19.9–41.8

Height, cm

  

Mean (SD)

131.6 (15.0)

134.4 (18.1)

Range

84.6–154.7

106.7–156.8

Height standardized score

  

Mean (SD)

1.5 (1.29)

1.4 (1.75)

Range

−1.4–3.4

−0.4–4.3

Tanner stage, n

  

Breast/genitalia      I

1b

0

      II

9   

2

      III

25

3

      IV

13

1

      V

1   

0

Basal LH, IU/L

  

Mean (SD)

2.0 (2.06)

1.6 (0.77)

Range

<0.15–11.1

0.73–2.6

Peak LH, IU/L

  

Mean (SD)

36.7 (21.8)

21.2 (9.1)

Range

12.0–119.2

13.5–38.8

History of menstrual bleeding, n

  

No

36

Yes

12

  1. aStart of study drug was delayed beyond 9 years old in one girl.
  2. bA one-year-old patient was enrolled in the trial with breast Tanner stage I based on qualifying peak stimulated LH (84.7 IU/L) and E2 (90 pg/mL).